Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients?

Journal of Arthroplasty

Volumn 27, Issue 8 SUPPL., 2012, Pages 55-60

  Smith, Eric B ^a   Wynne, Rachael ^a   Joshi, Ashish ^a   Liu, Hans ^a   Good, Robert P ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Antibiotic prophylaxis; Arthroplasty; Vancomycin

Indexed keywords

CEFAZOLIN; VANCOMYCIN;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PERIOPERATIVE PERIOD; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MALE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 84865394611     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.03.040     Document Type: Article

References (34)

1. Kuper M., Rosenstein A. Infection prevention in total knee and total hip arthroplasties. Am J Ortho 2008, 37:E2.
2. Berbari E.F., Hanssen A.D., Duffy M.C., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998, 27:1247.
3. Cataldo M.A., Petrosillo N., Cipriani M., et al. Prosthetic joint infection: recent developments in diagnosis and management. J Infect 2010, 61:443.
4. Parvizi J., Pawasarat I.M., Azzam K.A., et al. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. JOA 2010, 25(6 Sup):103.
5. American Academy of Orthopaedic Surgeons. Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty. 2011.
6. Carlsson A.K., Lidgren L., Lindberg L. Prophylactic antibiotics against early and late deep infections after total hip replacement. Acta Orthop Scand 1977, 48:405.
7. Hill C., Flamant R., Mazas F., et al. Prophylactic cefazolin versus placebo in total hip replacement: Report of a multicentre double-blind randomized trial. Lancet 1981, 1:795.
8. Stevens D.L. The role of vancomycin in the treatment paradigm. Clin Infect Dis 2006, 42(Suppl 1):S51.
9. Swoboda S., Helbig L., Kommerell M., et al. Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA. Pharm 2009, 64:407.
10. Meehan J., Jamali A.A., Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. JBJS 2009, 91:2480.
11. Center for Disease Control: Definition of HAI and Criteria for Specific Types of Infections. CDC.gov; January 2012.
12. Parvizi J., Zmistowski B., Berbari E.F., et al. New definition for periprosthetic joint infection: from the workgroup of the Musculoskeletal Infection Society. CORR 2011, 469:2992.
13. Kurtz S.M., Ong K.L., Lau E., et al. Prosthetic joint infection risk after TKA in the medicare population. CORR 2009.
14. Ong K.L., Kurtz S.M., Lau E., et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. JOA 2009, 24(6 Sup):105.
15. Lieberman J.R., Callaway G.H., Salvati E.A., et al. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. CORR 1994, 301:205.
16. Sherrell J.C., Fehring T.K., Odum S., et al. Fate of two-stage reimplantation after failed irrigation and debridement for periprosthetic knee infection. CORR 2011, 469:18.
17. Hartman M.B., Fehring T.K., Jordan L., et al. Periprosthetic knee sepsis. The role of irrigation and debridement. CORR 1991, 273:113.
18. Azzam K.A., Seeley M., Ghanem E., et al. Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. JOA 2010, 25:1022.
19. Deirmengian C., Greenbaum J., Lotke P.A., et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. JOA 2003, 18(7 sup 1):22.
20. Bradbury T., Fehring T.K., Taunton M., et al. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. JOA 2009, 24(6 sup):101.
21. Savarese A., Nanni M.L., Pasquali C., et al. Vancomycin prophylaxis and elective total joint arthroplasty. Chir Organi Mov 1999, 84:247.
22. Merrer J., Desbouchages L., Serazin V., et al. Comparison of routine prophylaxis with vancomycin or cefazolin for femoral neck fracture surgery: microbiological and clinical outcomes. Infect Control Hosp Epidemiol 2006, 27:1366.
23. Tacconelli E., Cataldo M.A., Albanese A., et al. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with high prevalence of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2008, 69:337.
24. Garey K.W., Lai D., Dao-Tran T.K., et al. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother 2008, 52:446.
25. Finkelstein R., Rabino G., Mashiah T., et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardionvasc Surg 2002, 123:326.
26. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., et al. Surgical site infections in orthopaedic surgery: the effect of mupirocin nasal ointment in a double blind, randomized, placebo-controlled study. Clin Infect Dis 2002, 35:353.
27. Perl T.M., Cullen J.J., Wenzel R.P., et al. Mupirocin and the risk of Staphylococcus aureus study team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. NEJM 2002, 346:1871.
28. van Rijen M.L., Kluytmans J.A. New approaches to prevention of staphylococcal infection in surgery. Curr Opin Infect Dis 2008, 21:380.
29. Prokuski L. Prophylactic antibiotics in orthopaedic surgery. JAAOS 2008, 16:283.
30. Rotger M., Trampuz A., Piper K.E., et al. Phenotypic and genotypic mupirocin resistance among Staphylococci causing periprosthetic joint infection. J Clin Micro 2005, 43:4266.
31. Harbarth S., Frankhauser C., Schrenzel J., et al. Universal Screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149.
32. Harbath S., Samore M.H., Lichtenberg D., et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on the surgical site infections and antimicrobial resistance. Circulation 2000, 101:2916.
33. Fulkerson E., Valle C.J., Wise B., et al. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am 2006, 88:1231.
34. Levinson W., Jawetz E. Medical microbiology and immunology 1996, 48. Appleton and Lange. Fourth ed.